{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:25:00Z","timestamp":1776119100235,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiorenal syndrome, <jats:italic>de novo<\/jats:italic> renal pathology arising secondary to cardiac insufficiency, is clinically recognised but poorly characterised. This study establishes and characterises a valid model representative of Type 2 cardiorenal syndrome. Extensive permanent left ventricular infarction, induced by ligation of the left anterior descending coronary artery in Lewis rats, was confirmed by plasma cardiac troponin I, histology and cardiac haemodynamics. Renal function and morphology was assessed 90-days post-ligation when heart failure had developed. The involvement of the paraventricular nucleus was investigated using markers of inflammation, apoptosis, reactive oxygen species and of angiotensin II involvement. An extensive left ventricular infarct was confirmed following coronary artery ligation, resulting in increased left ventricular weight and compromised left ventricular diastolic function and developed pressure. Glomerular filtration was significantly decreased, fractional excretion of sodium and caspase activities were increased and basement membrane thickening, indicating glomerulosclerosis, was evident. Interestingly, angiotensin II receptor I expression and reactive oxygen species levels in the hypothalamic paraventricular nucleus remained significantly increased at 90-days post-coronary artery ligation, suggesting that these hypothalamic changes may represent a novel, valuable pharmacological target. This model provides conclusive morphological, biochemical and functional evidence of renal injury consequent to heart failure, truly representative of Type-2 cardiorenal syndrome.<\/jats:p>","DOI":"10.1038\/s41598-020-58071-x","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:02:44Z","timestamp":1580122964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure"],"prefix":"10.1038","volume":"10","author":[{"given":"Joanne Clare","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott Duncan George","family":"Smart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma Maria Hinemoa","family":"Besley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Renee","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgayn Iona","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan Andrew","family":"Sammut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"58071_CR1","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J. Am. Coll. Cardiol. 52, 1527\u20131539 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58071_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0300-8932(10)70089-0","volume":"63","author":"F Pons","year":"2010","unstructured":"Pons, F. et al. Mortality and cause of death in patients with heart failure: findings at a specialist multidisciplinary heart failure unit. Rev. Esp. Cardiol. 63, 303\u2013314 (2010).","journal-title":"Rev. Esp. Cardiol."},{"key":"58071_CR3","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","volume":"47","author":"GL Smith","year":"2006","unstructured":"Smith, G. L. et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J. Am. Coll. Cardiol. 47, 1987\u20131996 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58071_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","volume":"27","author":"R de Silva","year":"2006","unstructured":"de Silva, R. et al. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur. Heart J. 27, 569\u2013581 (2006).","journal-title":"Eur. Heart J."},{"key":"58071_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","volume":"382","author":"KU Eckardt","year":"2013","unstructured":"Eckardt, K. U. et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 382, 158\u2013169 (2013).","journal-title":"Lancet."},{"key":"58071_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53, 589\u2013596 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58071_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.autneu.2010.01.005","volume":"155","author":"Y Oda","year":"2010","unstructured":"Oda, Y. et al. Renal insufficiency coexisting with heart failure is related to elevated sympathetic nerve activity. Auton. Neurosci. 155, 104\u2013108 (2010).","journal-title":"Auton. Neurosci."},{"key":"58071_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.surg.2007.07.041","volume":"143","author":"Y Park","year":"2008","unstructured":"Park, Y. et al. Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery. 143, 243\u2013251 (2008).","journal-title":"Surgery."},{"key":"58071_CR9","doi-asserted-by":"publisher","first-page":"Si","DOI":"10.1111\/j.1751-7133.2010.00176.x","volume":"16","author":"C Ronco","year":"2010","unstructured":"Ronco, C. & Maisel, A. Volume overload and cardiorenal syndromes. Congest. Heart Fail. 16, Si\u2013iv (2010).","journal-title":"Congest. Heart Fail."},{"key":"58071_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.amjcard.2009.10.020","volume":"105","author":"JM Testani","year":"2010","unstructured":"Testani, J. M. et al. Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am. J. Cardiol. 105, 511\u2013516 (2010).","journal-title":"Am. J. Cardiol."},{"key":"58071_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3317\/jraas.2004.024","volume":"5","author":"T Unger","year":"2004","unstructured":"Unger, T. & Li, J. The role of the renin-angiotensin-aldosterone system in heart failure. J. Renin Angiotensin Aldosterone Syst. 5, S7\u201310 (2004).","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"58071_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/FJC.0b013e3181f4f05a","volume":"56","author":"K Xu","year":"2010","unstructured":"Xu, K. et al. Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure. J. Cardiovasc. Pharmacol. 56, 506\u2013512 (2010).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"58071_CR13","doi-asserted-by":"publisher","first-page":"vii24","DOI":"10.1093\/ndt\/gfh1103","volume":"20","author":"A Shotan","year":"2005","unstructured":"Shotan, A. et al. Fluid overload contributing to heart failure. Nephrol. Dial. Transplant. 20, vii24\u2013vii27 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"58071_CR14","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00088.2010","volume":"300","author":"SC Clayton","year":"2011","unstructured":"Clayton, S. C., Haack, K. K. & Zucker, I. H. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am. J. Physiol. Ren. Physiol. 300, F31\u2013F39 (2011).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"58071_CR15","doi-asserted-by":"publisher","first-page":"F251","DOI":"10.1152\/ajprenal.00578.2013","volume":"307","author":"Y Yao","year":"2014","unstructured":"Yao, Y. et al. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 307, F251\u2013F262 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"58071_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cardfail.2009.12.022","volume":"16","author":"SR Goldsmith","year":"2010","unstructured":"Goldsmith, S. R., Sobotka, P. A. & Bart, B. A. The Sympathorenal Axis in Hypertension and Heart Failure. J. Card. Failure. 16, 369\u2013373 (2010).","journal-title":"J. Card. Failure."},{"key":"58071_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1113\/EP085021","volume":"100","author":"HP Thaung","year":"2015","unstructured":"Thaung, H. P. et al. Chronic bilateral renal denervation reduces cardiac hypertrophic remodelling but not beta-adrenergic responsiveness in hypertensive type 1 diabetic rats. Exp. Physiol. 100, 628\u2013639 (2015).","journal-title":"Exp. Physiol."},{"key":"58071_CR18","doi-asserted-by":"publisher","first-page":"F750","DOI":"10.1152\/ajprenal.00494.2011","volume":"302","author":"T Homma","year":"2012","unstructured":"Homma, T. et al. Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome. Am. J. Physiol. Ren. Physiol. 302, F750\u2013F761 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"58071_CR19","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1097\/01.ASN.0000145895.62896.98","volume":"15","author":"RP van Dokkum","year":"2004","unstructured":"van Dokkum, R. P. et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J. Am. Soc. Nephrol. 15, 3103\u20133110 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58071_CR20","first-page":"759","volume":"19","author":"SY Tang","year":"2015","unstructured":"Tang, S. Y., Peng, D. F., Hu, Y. J. & Chen, J. Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats. Eur. Rev. Med. Pharmacol. Sci. 19, 759\u2013766 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"58071_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1161\/CIRCRESAHA.107.158261","volume":"101","author":"FHH Leenen","year":"2007","unstructured":"Leenen, F. H. H. Brain Mechanisms Contributing to Sympathetic Hyperactivity and Heart Failure. Circ. Res. 101, 221\u2013223 (2007).","journal-title":"Circ. Res."},{"key":"58071_CR22","doi-asserted-by":"publisher","first-page":"H1898","DOI":"10.1152\/ajpheart.00488.2001","volume":"282","author":"J Francis","year":"2002","unstructured":"Francis, J. et al. Forebrain-mediated adaptations to myocardial infarction in the rat. Am. J. Physiol. Heart Circ. Physiol. 282, H1898\u2013H1906 (2002).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR23","doi-asserted-by":"crossref","unstructured":"Yin, J. et al. Mitochondria-Produced Superoxide Mediates Angiotensin II-Induced Inhibition of Neuronal Potassium Current. Am J Physiol Cell Physiol.ajpcell (2010).","DOI":"10.1152\/ajpcell.00313.2009"},{"key":"58071_CR24","doi-asserted-by":"publisher","first-page":"H2264","DOI":"10.1152\/ajpheart.01072.2003","volume":"286","author":"J Francis","year":"2004","unstructured":"Francis, J., Chu, Y., Johnson, A. K., Weiss, R. M. & Felder, R. B. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am. J. Physiol. Heart Circ. Physiol. 286, H2264\u2013H2271 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR25","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.biocel.2010.07.005","volume":"42","author":"E Badoer","year":"2010","unstructured":"Badoer, E. Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction. Int. J. Biochem. Cell Biol. 42, 1580\u20131585 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"58071_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2010.02.028","volume":"1326","author":"I Rana","year":"2010","unstructured":"Rana, I. et al. Microglia activation in the hypothalamic PVN following myocardial infarction. Brain Research. 1326, 96\u2013104 (2010).","journal-title":"Brain Research."},{"key":"58071_CR27","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1111\/j.1440-1681.2009.05234.x","volume":"37","author":"P Shi","year":"2010","unstructured":"Shi, P., Raizada, M. K. & Sumners, C. Brain cytokines as neuromodulators in cardiovascular control. Clin. Exp. Pharmacol. Physiol. 37, e52\u2013e57 (2010).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"58071_CR28","doi-asserted-by":"publisher","first-page":"H695","DOI":"10.1152\/ajpheart.00619.2003","volume":"287","author":"VM Campese","year":"2004","unstructured":"Campese, V. M. et al. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am. J. Physiol. Heart Circ. Physiol. 287, H695\u2013H703 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR29","doi-asserted-by":"publisher","first-page":"H599","DOI":"10.1152\/ajpheart.00286.2007","volume":"293","author":"A Guggilam","year":"2007","unstructured":"Guggilam, A. et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am. J. Physiol. Heart Circ. Physiol. 293, H599\u2013H609 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejheart.2008.05.004","volume":"10","author":"A Guggilam","year":"2008","unstructured":"Guggilam, A. et al. Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur. J. Heart Fail. 10, 625\u2013634 (2008).","journal-title":"Eur. J. Heart Fail."},{"key":"58071_CR31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCRESAHA.109.213025","volume":"106","author":"DW Infanger","year":"2010","unstructured":"Infanger, D. W. et al. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ. Res. 106, 1763\u20131774 (2010).","journal-title":"Circ. Res."},{"key":"58071_CR32","doi-asserted-by":"publisher","first-page":"H227","DOI":"10.1152\/ajpheart.01157.2007","volume":"295","author":"YM Kang","year":"2008","unstructured":"Kang, Y. M., Zhang, Z. H., Xue, B., Weiss, R. M. & Felder, R. B. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am. J. Physiol. Heart Circ. Physiol. 295, H227\u2013H236 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.HYP.0000231307.69761.2e","volume":"48","author":"S Ye","year":"2006","unstructured":"Ye, S., Zhong, H., Yanamadala, S. & Campese, V. M. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension. 48, 309\u2013315 (2006).","journal-title":"Hypertension."},{"key":"58071_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/HYPERTENSIONAHA.107.099796","volume":"51","author":"Y Yu","year":"2008","unstructured":"Yu, Y. et al. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension. 51, 727\u2013733 (2008).","journal-title":"Hypertension."},{"key":"58071_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1007792820944","volume":"11","author":"WB Kannel","year":"1997","unstructured":"Kannel, W. B. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc. Drugs Ther. 11, 199\u2013212 (1997).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"58071_CR36","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/oxfordjournals.eurheartj.a015196","volume":"18","author":"SH Poulsen","year":"1997","unstructured":"Poulsen, S. H., Jensen, S. E., Gotzsche, O. & Egstrup, K. Evaluation and prognostic significance of left ventricular diastolic function assessed by Doppler echocardiography in the early phase of a first acute myocardial infarction. Eur. Heart J. 18, 1882\u20131889 (1997).","journal-title":"Eur. Heart J."},{"key":"58071_CR37","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/01.RES.0000094744.88220.62","volume":"93","author":"Y Liao","year":"2003","unstructured":"Liao, Y. et al. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ. Res. 93, 759\u2013766 (2003).","journal-title":"Circ. Res."},{"key":"58071_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cardiores.2004.10.008","volume":"65","author":"Y Sugano","year":"2005","unstructured":"Sugano, Y. et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc. Res. 65, 446\u2013456 (2005).","journal-title":"Cardiovasc. Res."},{"key":"58071_CR39","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1093\/ndt\/gft376","volume":"28","author":"E Cho","year":"2013","unstructured":"Cho, E. et al. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol. Dial. Transplant. 28, 2766\u20132778 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"58071_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1006853112920","volume":"176","author":"J Ye","year":"1997","unstructured":"Ye, J. et al. A new technique of coronary artery ligation: experimental myocardial infarction in rats in vivo with reduced mortality. Mol. Cell Biochem. 176, 227\u2013233 (1997).","journal-title":"Mol. Cell Biochem."},{"key":"58071_CR41","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1113\/jphysiol.2014.273078","volume":"592","author":"S Lekawanvijit","year":"2014","unstructured":"Lekawanvijit, S. & Krum, H. Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J. Physiol. 592, 3969\u20133983 (2014).","journal-title":"J. Physiol."},{"key":"58071_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/08860220903389196","volume":"32","author":"IM Salman","year":"2010","unstructured":"Salman, I. M. et al. Renal ischemic injury affects renal hemodynamics and excretory functions in Sprague Dawley rats: involvement of renal sympathetic tone. Ren. Fail. 32, 96\u2013102 (2010).","journal-title":"Ren. Fail."},{"key":"58071_CR43","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1097\/00004872-200018100-00020","volume":"18","author":"J Bauersachs","year":"2000","unstructured":"Bauersachs, J. et al. Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252. J. Hypertens. 18, 1507\u20131514 (2000).","journal-title":"J. Hypertens."},{"key":"58071_CR44","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1023\/A:1015820316660","volume":"8","author":"IM Darling","year":"1991","unstructured":"Darling, I. M. & Morris, M. E. Evaluation of True Creatinine Clearance in Rats Reveals Extensive Renal Secretion. Pharm. Res. 8, 1318\u20131322 (1991).","journal-title":"Pharm. Res."},{"key":"58071_CR45","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1681\/ASN.2007101065","volume":"19","author":"AH Brantsma","year":"2008","unstructured":"Brantsma, A. H., Bakker, S. J., de, Z. D., de Jong, P. E. & Gansevoort, R. T. Extended prognostic value of urinary albumin excretion for cardiovascular events. J. Am. Soc. Nephrol. 19, 1785\u20131791 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58071_CR46","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/archinte.167.22.2490","volume":"167","author":"S Hallan","year":"2007","unstructured":"Hallan, S. et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch. Intern. Med. 167, 2490\u20132496 (2007).","journal-title":"Arch. Intern. Med."},{"key":"58071_CR47","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","volume":"374","author":"CE Jackson","year":"2009","unstructured":"Jackson, C. E. et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 374, 543\u2013550 (2009).","journal-title":"Lancet."},{"key":"58071_CR48","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1681\/ASN.2005121273","volume":"17","author":"SI Hallan","year":"2006","unstructured":"Hallan, S. I. et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J. Am. Soc. Nephrol. 17, 2275\u20132284 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58071_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ijcard.2014.11.033","volume":"179","author":"Z Dong","year":"2015","unstructured":"Dong, Z. et al. Myocardial infarction accelerates glomerular injury and microalbuminuria in diabetic rats via local hemodynamics and immunity. Int. J. Cardiol. 179, 397\u2013408 (2015).","journal-title":"Int. J. Cardiol."},{"key":"58071_CR50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10157-003-0249-8","volume":"7","author":"S Arima","year":"2003","unstructured":"Arima, S. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics. Clin. Exp. Nephrol. 7, 172\u2013178 (2003).","journal-title":"Clin. Exp. Nephrol."},{"key":"58071_CR51","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cardfail.2010.06.417","volume":"16","author":"S Masson","year":"2010","unstructured":"Masson, S. et al. Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). J. Card. Fail. 16, 964\u2013970 (2010).","journal-title":"J. Card. Fail."},{"key":"58071_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","volume":"67","author":"W Kriz","year":"2005","unstructured":"Kriz, W. & Lehir, M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 67, 404\u2013419 (2005).","journal-title":"Kidney Int."},{"key":"58071_CR53","first-page":"viii7","volume":"18","author":"D Silverberg","year":"2003","unstructured":"Silverberg, D., Wexler, D., Blum, M., Wollman, Y. & Iaina, A. The cardio-renal anaemia syndrome: does it exist? Nephrol. Dial. Transplant. 18, viii7\u201312 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"key":"58071_CR54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.semnephrol.2006.05.006","volume":"26","author":"DS Silverberg","year":"2006","unstructured":"Silverberg, D. S., Wexler, D., Iaina, A. & Schwartz, D. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin. Nephrol. 26, 296\u2013306 (2006).","journal-title":"Semin. Nephrol."},{"key":"58071_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","volume":"173","author":"M Bujak","year":"2008","unstructured":"Bujak, M. et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am. J. Pathol. 173, 57\u201367 (2008).","journal-title":"Am. J. Pathol."},{"key":"58071_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.12.015","volume":"38","author":"D Gurantz","year":"2005","unstructured":"Gurantz, D. et al. IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart. J. Mol. Cell Cardiol. 38, 505\u2013515 (2005).","journal-title":"J. Mol. Cell Cardiol."},{"key":"58071_CR57","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/eurheartj\/ehv268","volume":"36","author":"M Edner","year":"2015","unstructured":"Edner, M., Benson, L., Dahlstrom, U. & Lund, L. H. Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study. Eur. Heart J. 36, 2318\u20132326 (2015).","journal-title":"Eur. Heart J."},{"key":"58071_CR58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1053\/j.ajkd.2010.04.012","volume":"56","author":"AA House","year":"2010","unstructured":"House, A. A., Haapio, M., Lassus, J., Bellomo, R. & Ronco, C. Therapeutic strategies for heart failure in cardiorenal syndromes. Am. J. Kidney Dis. 56, 759\u2013773 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"58071_CR59","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1681\/ASN.2005050522","volume":"16","author":"Y Izuhara","year":"2005","unstructured":"Izuhara, Y. et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J. Am. Soc. Nephrol. 16, 3631\u20133641 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58071_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cardiores.2006.03.017","volume":"71","author":"YL Li","year":"2006","unstructured":"Li, Y. L. et al. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 71, 129\u2013138 (2006).","journal-title":"Cardiovasc. Res."},{"key":"58071_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/00313021003631304","volume":"42","author":"IM Salman","year":"2010","unstructured":"Salman, I. M. et al. Role of the renal sympathetic nervous system in mediating renal ischaemic injury-induced reductions in renal haemodynamic and excretory functions. Pathology. 42, 259\u2013266 (2010).","journal-title":"Pathology."},{"key":"58071_CR62","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1097\/01.hjh.0000179763.02583.8e","volume":"23","author":"J Stegbauer","year":"2005","unstructured":"Stegbauer, J. et al. Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J. Hypertens. 23, 1691\u20131698 (2005).","journal-title":"J. Hypertens."},{"key":"58071_CR63","doi-asserted-by":"publisher","first-page":"R913","DOI":"10.1152\/ajpregu.00250.2005","volume":"289","author":"CS Wilcox","year":"2005","unstructured":"Wilcox, C. S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R913\u2013R935 (2005).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"58071_CR64","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.CIR.99.4.570","volume":"99","author":"A Wada","year":"1999","unstructured":"Wada, A. et al. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism. Circ. 99, 570\u2013577 (1999).","journal-title":"Circ."},{"key":"58071_CR65","doi-asserted-by":"publisher","first-page":"F655","DOI":"10.1152\/ajprenal.00373.2009","volume":"298","author":"A Whaley-Connell","year":"2010","unstructured":"Whaley-Connell, A. et al. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. Am. J. Physiol. Ren. Physiol. 298, F655\u2013F661 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"58071_CR66","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0895-7061(02)02959-X","volume":"15","author":"S Ye","year":"2002","unstructured":"Ye, S., Zhong, H., Yanamadala, V. & Campese, V. M. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am. J. Hypertens. 15, 717\u2013724 (2002).","journal-title":"Am. J. Hypertens."},{"key":"58071_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.toxlet.2015.04.008","volume":"235","author":"M Zhang","year":"2015","unstructured":"Zhang, M. et al. Endogenous hydrogen peroxide in the hypothalamic paraventricular nucleus regulates neurohormonal excitation in high salt-induced hypertension. Toxicol. Lett. 235, 206\u2013215 (2015).","journal-title":"Toxicol. Lett."},{"key":"58071_CR68","doi-asserted-by":"publisher","first-page":"H880","DOI":"10.1152\/ajpheart.00095.2015","volume":"309","author":"MJ Huber","year":"2015","unstructured":"Huber, M. J. et al. Activation of the (pro)renin receptor in the paraventricular nucleus increases sympathetic outflow in anesthetized rats. Am. J. Physiol. Heart Circ. Physiol. 309, H880\u2013H887 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/cvn119","volume":"79","author":"YM Kang","year":"2008","unstructured":"Kang, Y. M. et al. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc. Res. 79, 671\u2013678 (2008).","journal-title":"Cardiovasc. Res."},{"key":"58071_CR70","doi-asserted-by":"publisher","first-page":"H1828","DOI":"10.1152\/ajpheart.01245.2003","volume":"287","author":"GQ Zhu","year":"2004","unstructured":"Zhu, G. Q. et al. AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am. J. Physiol. - Heart Circulatory Physiology. 287, H1828\u2013H1835 (2004).","journal-title":"Am. J. Physiol. - Heart Circulatory Physiology."},{"key":"58071_CR71","doi-asserted-by":"publisher","first-page":"H2138","DOI":"10.1152\/ajpheart.00112.2004","volume":"287","author":"J Francis","year":"2004","unstructured":"Francis, J., Wei, S. G., Weiss, R. M. & Felder, R. B. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am. J. Physiol. Heart Circ. Physiol. 287, H2138\u2013H2146 (2004).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"58071_CR72","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1540-8191.2005.00139.x","volume":"20","author":"K Nakamura","year":"2005","unstructured":"Nakamura, K., Al-Ruzzeh, S., Ilsley, C., Yacoub, M. H. & Amrani, M. Acute effect of cerivastatin on cardiac regional ischemia in a rat model mimicking off-pump coronary surgery. J. Card. Surg. 20, 507\u2013511 (2005).","journal-title":"J. Card. Surg."},{"key":"58071_CR73","doi-asserted-by":"publisher","first-page":"H722","DOI":"10.1152\/ajpcell.1997.272.6.C1919","volume":"272","author":"YH Liu","year":"1997","unstructured":"Liu, Y. H. et al. Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. Am. J. Physiol. 272, H722\u2013H727 (1997).","journal-title":"Am. J. Physiol."},{"key":"58071_CR74","doi-asserted-by":"publisher","first-page":"I308","DOI":"10.1161\/hc37t1.094871","volume":"104","author":"K Suzuki","year":"2001","unstructured":"Suzuki, K. et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circ. 104, I308\u2013I3I3 (2001).","journal-title":"Circ."},{"key":"58071_CR75","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1096\/fj.05-3718com","volume":"19","author":"VJ Adlam","year":"2005","unstructured":"Adlam, V. J. et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19, 1088\u20131095 (2005).","journal-title":"FASEB J."},{"key":"58071_CR76","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0002-9440(10)64138-7","volume":"158","author":"IA Sammut","year":"2001","unstructured":"Sammut, I. A. et al. Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. Am. J. Pathol. 158, 1821\u20131831 (2001).","journal-title":"Am. J. Pathol."},{"key":"58071_CR77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein Measurement with the Folin Phenol Reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58071-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58071-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58071-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:03:27Z","timestamp":1670306607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58071-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58071"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58071-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1261"}}